Palisade Bio (PALI) Operating Leases (2019 - 2024)
Palisade Bio (PALI) posted quarterly Operating Leases of $24000.0 for Q2 2024, down 84.31% year-over-year from $153000.0 in Q3 2023, and down 58.62% quarter-over-quarter from $58000.0 in Q1 2024.
Powered by 
Analysis
Palisade Bio (PALI) Operating Leases (2019 - 2024) Analysis & Trends
Palisade Bio (PALI) has reported Operating Leases for 6 consecutive years, with $24000.0 the latest figure, recorded in Q2 2024.
- In Q2 2024, Operating Leases fell 84.31% year-over-year to $24000.0; the TTM figure through Jun 2024 stood at $24000.0 (down 84.31% YoY), while the FY2023 annual figure was $90000.0, down 57.35% from the prior year.
- Operating Leases eased to $24000.0 in Q2 2024 per PALI's latest filing, from $58000.0 in the prior quarter.
- Across five years, Operating Leases topped out at $364000.0 in Q2 2022 and bottomed at $24000.0 in Q2 2024.
- Historically, Operating Leases has averaged $155754.6 across 5 years, with a median of $144697.5 in 2020.
- Annual changes were most pronounced in 2022 — Operating Leases soared 81.09% — and 2024, when it tumbled 84.31%.
- Palisade Bio's Operating Leases stood at $112000.0 in 2020, then jumped by 79.46% to $201000.0 in 2021, then grew by 4.98% to $211000.0 in 2022, then plunged by 57.35% to $90000.0 in 2023, then plunged by 73.33% to $24000.0 in 2024.
- Business Quant data shows PALI's Operating Leases at $24000.0 in Q2 2024, $58000.0 in Q1 2024, and $90000.0 in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Palisade Bio | 440.73 Mn | 315.53 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 24,000.00 |
| Mar 31, 2024 | 58,000.00 |
| Dec 31, 2023 | 90,000.00 |
| Sep 30, 2023 | 122,000.00 |
| Jun 30, 2023 | 153,000.00 |
| Mar 31, 2023 | 182,000.00 |
| Dec 31, 2022 | 211,000.00 |
| Sep 30, 2022 | 340,000.00 |
| Jun 30, 2022 | 364,000.00 |
| Sep 30, 2021 | 158,000.00 |
| Jun 30, 2021 | 201,000.00 |
| Dec 31, 2020 | 112,000.00 |
| Sep 30, 2020 | 159,400.00 |
| Jun 30, 2020 | 128,770.00 |
| Mar 31, 2020 | 136,395.00 |
| Dec 31, 2019 | 148,543.00 |
| Sep 30, 2019 | 183,520.00 |